Can Fite Biopharma Ltd (CANF) Releases Quarterly Earnings, Beats Estimates By $0.16 EPS
Can Fite Biopharma Ltd (NASDAQ:CANF) released its earnings data on Wednesday. The company reported ($0.20) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.36) by $0.16, AR Network reports.
Shares of Can Fite Biopharma Ltd (NASDAQ:CANF) opened at 3.81 on Wednesday. Can Fite Biopharma Ltd has a one year low of $3.30 and a one year high of $9.46. The stock’s 50-day moving average is $3.88 and its 200-day moving average is $4.59. The company’s market cap is $31.0 million.
Can Fite Biofarma Ltd is an Israel-based biopharmaceutical company. The Company develops new treatments for autoimmune diseases and cancer.
Receive News & Ratings for Can Fite Biopharma Ltd (ADR) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Can Fite Biopharma Ltd (ADR) and related companies with Analyst Ratings Network's FREE daily email newsletter.